Effectiveness of Acupuncture for Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis

Primary ovarian insufficiency (POI) affects 1-2% of women under 40 years of age, causing amenorrhea, infertility, and menopausal symptoms due to premature ovarian dysfunction. This systematic review and meta-analysis, conducted by Korean researchers, represents the first comprehensive study on the use of acupuncture to treat this complex condition.

The researchers conducted an extensive search across 12 databases, including international and Asian sources, identifying 8 randomized clinical trials that included 620 participants. All studies were conducted in China and published in Chinese, reflecting the traditional use of acupuncture in Eastern medicine for reproductive disorders.

The interventions varied considerably across studies. Four trials used acupuncture alone, while others combined acupuncture with hormone therapy or Chinese herbal medicine. Modalities included traditional manual acupuncture, electroacupuncture, and catgut implantation at specific points. The most commonly used points were CV-4, CV-6, SP-6, BL-20, and BL-23, all related to the regulation of reproductive function in traditional Chinese medicine.

Primary outcomes showed statistically significant benefits for acupuncture. Serum FSH levels, an important marker of ovarian function, decreased significantly in the acupuncture group compared with controls (mean difference of -9.26 IU/L). Estradiol, a hormone essential for female reproductive function, increased on average by 31.51 pmol/L in the acupuncture-treated groups. More striking was the rate of return of menstruation: 25% more women in the acupuncture group recovered menstruation compared with control groups.

However, the authors emphasize that these seemingly promising results must be interpreted with significant caution. The methodological quality of the included studies was generally low, with serious bias problems. No study adequately implemented blinding of participants or assessors, a crucial aspect in acupuncture research. Random sequence generation and allocation concealment were inadequately reported in most studies.

Small sample size represents another important limitation. Individual studies included only 23 to 168 participants each, and none reported formal sample-size calculations. This limitation compromises the statistical power of the findings and their ability to detect clinically meaningful differences.

Regarding safety, only two of the eight studies reported information on adverse events, which were described as mild (bruising, induration, and slight edema). The absence of safety reporting in most studies does not mean the treatment is safe, highlighting the need for more rigorous monitoring in future research.

Clinical heterogeneity across studies also complicates the interpretation of the results. Diagnostic criteria for POI varied, not always following established international standards. Some studies did not adequately report hormone levels or duration of amenorrhea, factors crucial for characterizing the condition.

The authors used GRADE criteria to evaluate the quality of the evidence, classifying it as 'low' for FSH and return of menstruation, and 'very low' for estradiol and menopausal symptoms. This classification reflects significant risk of bias, imprecision due to small sample sizes, and possible publication bias.

In terms of clinical application, although the results suggest therapeutic potential of acupuncture for POI, current evidence is insufficient for definitive recommendations. Acupuncture may represent an interesting adjunctive option, especially considering that therapeutic alternatives for POI are limited. However, higher-quality clinical trials with larger samples, better methodological control, and long-term follow-up are needed to definitively establish the efficacy and safety of acupuncture in this population.